BaseLaunch partners with scientists and entrepreneurs to help launch and grow exceptional biotech ventures from inception to Series A funding. BaseLaunch actively aims to build out companies and complement the (usually) academic inventors and scientist with biopharma professionals. We collaborate closely with key biopharma players: Roche, Pureos Bioventures, Roivant Sciences, Bridge Bioventures, CSL Behring, Johnson & Johnson and China Medical System. Since early 2018, 20 ventures have been supported, 10 of which have, in total, raised over $450 million in financing. One company has been sold and several collaborations have been initiated.